Be a Smart Investor
Monday, January 8, 2018
Celgene nears deal to buy Impact Biomedicines for as much as $7 billion
Celgene is expected to announce Monday that it is acquiring Impact Biomedicines for as much as $7 billion, The Wall Street Journal reported Sunday.
from Mergers and Acquisitions http://ift.tt/2qDxf2B
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment